Kishan Amar U, Duchesne Gillian, Wang Pin-Chieh, Rwigema Jean-Claude M, Kishan Arun U, Saigal Christopher, Rettig Matthew, Steinberg Michael L, King Christopher R
Departments of Radiation Oncology.
Sir Peter MacCallum Department of Oncology, the University of Melbourne, Vic., Australia.
Am J Clin Oncol. 2018 Aug;41(8):739-746. doi: 10.1097/COC.0000000000000381.
To query specialty-specific differences regarding postoperative radiotherapy (RT) for high-risk prostate cancer.
Electronic mail survey of radiation oncologists (ROs) and urologists. We sought to maximize absolute response number to capture contemporary practice ethos. The outcome of interest was association between response and specialty. Training level/expertise, practice setting, percentage of consultation caseload consisting of high-risk prostate cancer, and nationality were set as effect modifiers for multivariate logistic regression.
In total, 846 ROs and 407 urologists responded. ROs were more likely to prefer adjuvant radiotherapy (ART). ART or early salvage radiotherapy (SRT, with early SRT defined as that delivered at prostate-specific antigen<0.2), whereas urologists were more likely to prefer early or delayed SRT (P<0.0001). ROs were more likely to prefer lower PSA thresholds for initiating SRT (P<0.0001), and more likely to recommend ART in the setting of adverse pathologic features or node-positive disease (P<0.0001). Significantly more ROs would recommend concurrent androgen deprivation therapy or pelvic nodal RT in the setting of node-positive or Gleason score 8 to 10 disease (P<0.0001).
Specialty-specific differences were readily elucidated with respect to timing and indications for ART and SRT, as well as for indications for androgen deprivation therapy and nodal RT. These differences are likely to create a sense of dissonance for patients, which may in turn explain the underutilization of postoperative RT in general practice.
探究高危前列腺癌术后放疗在不同专业之间的差异。
对放射肿瘤学家(ROs)和泌尿科医生进行电子邮件调查。我们力求最大化绝对回复数量,以捕捉当代的实践理念。感兴趣的结果是回复与专业之间的关联。将培训水平/专业技能、执业环境、高危前列腺癌会诊病例占比以及国籍设定为多因素逻辑回归的效应修饰因素。
共有846名放射肿瘤学家和407名泌尿科医生回复。放射肿瘤学家更倾向于辅助放疗(ART)。ART或早期挽救性放疗(SRT,早期SRT定义为在前列腺特异性抗原<0.2时进行的放疗),而泌尿科医生更倾向于早期或延迟SRT(P<0.0001)。放射肿瘤学家更倾向于采用较低的PSA阈值启动SRT(P<0.0001),并且在出现不良病理特征或淋巴结阳性疾病时更倾向于推荐ART(P<0.0001)。在淋巴结阳性或Gleason评分8至10的疾病中,明显更多的放射肿瘤学家会推荐同时进行雄激素剥夺治疗或盆腔淋巴结放疗(P<0.0001)。
在ART和SRT的时机和适应症以及雄激素剥夺治疗和淋巴结放疗的适应症方面,不同专业之间的差异很容易被阐明。这些差异可能会让患者产生不一致的感觉,这反过来可能解释了在一般实践中术后放疗的利用率较低的原因。